Literature DB >> 11500423

Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.

Y He1, R Vemulapalli, A Zeytun, G G Schurig.   

Abstract

A safe, more sensitive, nonradioactive, neutral red uptake assay was adopted to replace the traditional 51Cr release assay for detection of Brucella-specific cytotoxic T lymphocyte (CTL) activity. Our studies indicated that Brucella abortus strain RB51 vaccination of mice induced specific CTLs against both strain RB51- and strain 2308-infected J774.A1 macrophages but not against Listeria monocytogenes-infected J774.A1 cells. The antigen-specific cytotoxic activity was exerted by T lymphocytes but not by NK cells. CD3+ CD4+ T cells secreted the highest level of gamma interferon (IFN-gamma) and were able to exert a low but significant level of specific lysis of Brucella-infected macrophages. They also exerted a low level of nonspecific lysis of noninfected macrophages. In contrast, CD3+ CD8+ T cells secreted low levels of IFN-gamma but demonstrated high levels of specific lysis of Brucella-infected macrophages with no nonspecific lysis. These findings indicate that B. abortus strain RB51 vaccination of mice induces specific CTLs and suggest that CD3+ CD4+ and CD3+ CD8+ T cells play a synergistic role in the anti-Brucella activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500423      PMCID: PMC98663          DOI: 10.1128/IAI.69.9.5502-5508.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo.

Authors:  M Heinkelein; I Euler-König; H Klinker; H Rückle-Lanz; C Jassoy
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

Review 2.  Fas antigen (CD95) and hematopoietic progenitor cells.

Authors:  K Nagafuji; K Takenaka; T Shibuya; M Harada; Y Niho
Journal:  Leuk Lymphoma       Date:  1996-12

Review 3.  P2 purinoceptors in the immune system.

Authors:  F Di Virgilio; D Ferrari; S Falzoni; P Chiozzi; M Munerati; T H Steinberg; O R Baricordi
Journal:  Ciba Found Symp       Date:  1996

4.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.

Authors:  C Martinez; M Delgado; R P Gomariz; D Ganea
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

5.  Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308.

Authors:  D M Fernandes; X Jiang; J H Jung; C L Baldwin
Journal:  FEMS Immunol Med Microbiol       Date:  1996-12-31

Review 6.  Regulation of the interferon system and cell growth by the IRF transcription factors.

Authors:  T Taniguchi; H Harada; M Lamphier
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Target cells of cytotoxic T lymphocytes directed to the individual structural proteins of rabies virus.

Authors:  H Fujii; K Mannen; Y Takita-Sonoda; K Hirai; M S Cruz-Abrenica; Y Kawano; A Nishizono; K Mifune
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

8.  Age-related effects of ectopic pituitary transplants on the activation of Ames dwarf mouse lymphocytes in vitro.

Authors:  A I Esquifino; A Szary; H M Brown-Borg; A Bartke
Journal:  Proc Soc Exp Biol Med       Date:  1996-01

9.  CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice.

Authors:  S C Oliveira; G A Splitter
Journal:  Eur J Immunol       Date:  1995-09       Impact factor: 5.532

10.  Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts.

Authors:  Y Zhan; A Kelso; C Cheers
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  34 in total

1.  Mechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival.

Authors:  Mingxing Tian; Jing Qu; Xiangan Han; Chan Ding; Shaohui Wang; Daxin Peng; Shengqing Yu
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

2.  A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.

Authors:  Juliana Cassataro; Carlos A Velikovsky; Silvia de la Barrera; Silvia M Estein; Laura Bruno; Raúl Bowden; Karina A Pasquevich; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.

Authors:  Neelima Sanakkayala; Anna Sokolovska; Jatinder Gulani; Harm Hogenesch; Nammalwar Sriranganathan; Stephen M Boyle; Gerhardt G Schurig; Ramesh Vemulapalli
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

Review 4.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

5.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway.

Authors:  Lis N Velásquez; M Ayelén Milillo; M Victoria Delpino; Aldana Trotta; M Florencia Mercogliano; Roberto G Pozner; Roxana Schillaci; Patricia V Elizalde; Guillermo H Giambartolomei; Paula Barrionuevo
Journal:  Immunol Cell Biol       Date:  2016-11-29       Impact factor: 5.126

7.  Literature-based discovery of IFN-gamma and vaccine-mediated gene interaction networks.

Authors:  Arzucan Ozgür; Zuoshuang Xiang; Dragomir R Radev; Yongqun He
Journal:  J Biomed Biotechnol       Date:  2010-06-03

8.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

9.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06

10.  Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus.

Authors:  Fang Chen; Yongqun He
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.